Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 01762665
Rekha Nahar is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at XITIZ PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01762665.Rekha Nahar has previously been associated with 1 company in roles such as Director.Rekha Nahar is currently involved in 2 different roles. Their most recent position is with ENLIGHTEN INFRA PROJECTS PRIVATE LIMITED as a Additional Director. The first company Rekha Nahar was appointed to as a director was XITIZ PHARMA PRIVATE LIMITED. Rekha Nahar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rekha Nahar is currently associated with 2 companies in various capacities such as Director and Additional Director. They serve as a Director at XITIZ PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01762665.Rekha Nahar has previously been associated with 1 company in roles such as Director.Rekha Nahar is currently involved in 2 different roles. Their most recent position is with ENLIGHTEN INFRA PROJECTS PRIVATE LIMITED as a Additional Director. The first company Rekha Nahar was appointed to as a director was XITIZ PHARMA PRIVATE LIMITED. Rekha Nahar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
5y 5m 2y 9m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| XITIZ PHARMA PRIVATE LIMITED | Director | 03-Nov-1998 |
| ENLIGHTEN INFRA PROJECTS PRIVATE LIMITED | Additional Director | 08-Mar-2017 |